0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibody-drug Conjugates Market Outlook 2022
Published Date: December 2021
|
Report Code: QYRE-Auto-30Y41
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Antibody drug Conjugates Market Outlook 2022

Global Antibody-drug Conjugates Market Outlook 2022

Code: QYRE-Auto-30Y41
Report
December 2021
91 Pages
QYResearch
Region: Global, North America, Europe, Asia Pacific, Central & South America, Africa, Middle East,
Description
Table of Content
Tables & Figures
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.

The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.

The global Antibody-drug Conjugates market was valued at US$ 2734.4 million in 2020 and is expected to reach US$ 3729.7 million by the end of 2027, growing at a CAGR of 4.7% during 2021-2027.

This report focuses on Antibody-drug Conjugates volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antibody-drug Conjugates market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Antibody-drug Conjugates Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Adcetris
Kadcyla

Segment by Application

Breast Cancer
Lymphoma

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

BY COMPANY

ImmunoGen
Seattle Genetics
Roche
Takeda
1 Antibody-drug Conjugates Market Overview
1.1 Product Overview and Scope of Antibody-drug Conjugates
1.2 Antibody-drug Conjugates Segment by Type
1.2.1 Global Antibody-drug Conjugates Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Antibody-drug Conjugates Segment by Application
1.3.1 Global Antibody-drug Conjugates Sales Comparison by Application: (2021-2027)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugates Market Size Estimates and Forecasts
1.4.1 Global Antibody-drug Conjugates Revenue 2016-2027
1.4.2 Global Antibody-drug Conjugates Sales 2016-2027
1.4.3 Antibody-drug Conjugates Market Size by Region: 2016 Versus 2021 Versus 2027
2 Antibody-drug Conjugates Market Competition by Manufacturers
2.1 Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antibody-drug Conjugates Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antibody-drug Conjugates Manufacturing Sites, Area Served, Product Type
2.5 Antibody-drug Conjugates Market Competitive Situation and Trends
2.5.1 Antibody-drug Conjugates Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antibody-drug Conjugates Players Market Share by Revenue
2.5.3 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibody-drug Conjugates Retrospective Market Scenario by Region
3.1 Global Antibody-drug Conjugates Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Antibody-drug Conjugates Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Antibody-drug Conjugates Market Facts & Figures by Country
3.3.1 North America Antibody-drug Conjugates Sales by Country
3.3.2 North America Antibody-drug Conjugates Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antibody-drug Conjugates Market Facts & Figures by Country
3.4.1 Europe Antibody-drug Conjugates Sales by Country
3.4.2 Europe Antibody-drug Conjugates Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibody-drug Conjugates Market Facts & Figures by Region
3.5.1 Asia Pacific Antibody-drug Conjugates Sales by Region
3.5.2 Asia Pacific Antibody-drug Conjugates Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antibody-drug Conjugates Market Facts & Figures by Country
3.6.1 Latin America Antibody-drug Conjugates Sales by Country
3.6.2 Latin America Antibody-drug Conjugates Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antibody-drug Conjugates Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibody-drug Conjugates Sales by Country
3.7.2 Middle East and Africa Antibody-drug Conjugates Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antibody-drug Conjugates Historic Market Analysis by Type
4.1 Global Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
4.2 Global Antibody-drug Conjugates Revenue Market Share by Type (2016-2021)
4.3 Global Antibody-drug Conjugates Price by Type (2016-2021)
5 Global Antibody-drug Conjugates Historic Market Analysis by Application
5.1 Global Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
5.2 Global Antibody-drug Conjugates Revenue Market Share by Application (2016-2021)
5.3 Global Antibody-drug Conjugates Price by Application (2016-2021)
6 Key Companies Profiled
6.1 ImmunoGen
6.1.1 ImmunoGen Corporation Information
6.1.2 ImmunoGen Description and Business Overview
6.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
6.1.4 ImmunoGen Antibody-drug Conjugates Product Portfolio
6.1.5 ImmunoGen Recent Developments/Updates
6.2 Seattle Genetics
6.2.1 Seattle Genetics Corporation Information
6.2.2 Seattle Genetics Description and Business Overview
6.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Seattle Genetics Antibody-drug Conjugates Product Portfolio
6.2.5 Seattle Genetics Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Roche Antibody-drug Conjugates Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Corporation Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Takeda Antibody-drug Conjugates Product Portfolio
6.4.5 Takeda Recent Developments/Updates
7 Antibody-drug Conjugates Manufacturing Cost Analysis
7.1 Antibody-drug Conjugates Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibody-drug Conjugates
7.4 Antibody-drug Conjugates Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibody-drug Conjugates Distributors List
8.3 Antibody-drug Conjugates Customers
9 Antibody-drug Conjugates Market Dynamics
9.1 Antibody-drug Conjugates Industry Trends
9.2 Antibody-drug Conjugates Growth Drivers
9.3 Antibody-drug Conjugates Market Challenges
9.4 Antibody-drug Conjugates Market Restraints
10 Global Market Forecast
10.1 Antibody-drug Conjugates Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibody-drug Conjugates by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antibody-drug Conjugates by Type (2022-2027)
10.2 Antibody-drug Conjugates Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibody-drug Conjugates by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antibody-drug Conjugates by Application (2022-2027)
10.3 Antibody-drug Conjugates Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibody-drug Conjugates by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antibody-drug Conjugates by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Antibody-drug Conjugates Sales (Kg) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Antibody-drug Conjugates Sales (Kg) Comparison by Application (2021-2027)
    Table 3. Global Antibody-drug Conjugates Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Antibody-drug Conjugates Covered in This Study
    Table 5. Global Antibody-drug Conjugates Sales (Kg) of Key Manufacturers (2016-2021)
    Table 6. Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Antibody-drug Conjugates Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Antibody-drug Conjugates Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Antibody-drug Conjugates Average Price (USD/Kg) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Antibody-drug Conjugates Manufacturing Sites and Area Served
    Table 11. Manufacturers Antibody-drug Conjugates Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugates as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg)
    Table 16. Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021)
    Table 17. Global Antibody-drug Conjugates Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)
    Table 19. North America Antibody-drug Conjugates Sales Market Share by Country (2016-2021)
    Table 20. North America Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Antibody-drug Conjugates Revenue Market Share by Country (2016-2021)
    Table 22. Europe Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)
    Table 23. Europe Antibody-drug Conjugates Sales Market Share by Country (2016-2021)
    Table 24. Europe Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Antibody-drug Conjugates Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Antibody-drug Conjugates Sales by Region (2016-2021) & (Kg)
    Table 27. Asia Pacific Antibody-drug Conjugates Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Antibody-drug Conjugates Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Antibody-drug Conjugates Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)
    Table 31. Latin America Antibody-drug Conjugates Sales Market Share by Country (2016-2021)
    Table 32. Latin America Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Antibody-drug Conjugates Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Antibody-drug Conjugates Sales by Country (2016-2021) & (Kg)
    Table 35. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Antibody-drug Conjugates Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Country (2016-2021)
    Table 38. Global Antibody-drug Conjugates Sales (Kg) by Type (2016-2021)
    Table 39. Global Antibody-drug Conjugates Sales Market Share by Type (2016-2021)
    Table 40. Global Antibody-drug Conjugates Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Antibody-drug Conjugates Revenue Share by Type (2016-2021)
    Table 42. Global Antibody-drug Conjugates Price (USD/Kg) by Type (2016-2021)
    Table 43. Global Antibody-drug Conjugates Sales (Kg) by Application (2016-2021)
    Table 44. Global Antibody-drug Conjugates Sales Market Share by Application (2016-2021)
    Table 45. Global Antibody-drug Conjugates Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Antibody-drug Conjugates Revenue Share by Application (2016-2021)
    Table 47. Global Antibody-drug Conjugates Price (USD/Kg) by Application (2016-2021)
    Table 48. ImmunoGen Corporation Information
    Table 49. ImmunoGen Description and Business Overview
    Table 50. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 51. ImmunoGen Antibody-drug Conjugates Product
    Table 52. ImmunoGen Recent Developments/Updates
    Table 53. Seattle Genetics Corporation Information
    Table 54. Seattle Genetics Description and Business Overview
    Table 55. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 56. Seattle Genetics Antibody-drug Conjugates Product
    Table 57. Seattle Genetics Recent Developments/Updates
    Table 58. Roche Corporation Information
    Table 59. Roche Description and Business Overview
    Table 60. Roche Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 61. Roche Antibody-drug Conjugates Product
    Table 62. Roche Recent Developments/Updates
    Table 63. Takeda Corporation Information
    Table 64. Takeda Description and Business Overview
    Table 65. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 66. Takeda Antibody-drug Conjugates Product
    Table 67. Takeda Recent Developments/Updates
    Table 68. Production Base and Market Concentration Rate of Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Antibody-drug Conjugates Distributors List
    Table 71. Antibody-drug Conjugates Customers List
    Table 72. Antibody-drug Conjugates Market Trends
    Table 73. Antibody-drug Conjugates Growth Drivers
    Table 74. Antibody-drug Conjugates Market Challenges
    Table 75. Antibody-drug Conjugates Market Restraints
    Table 76. Global Antibody-drug Conjugates Sales Forecast by Type (2022-2027) & (Kg)
    Table 77. Global Antibody-drug Conjugates Sales Market Share Forecast by Type (2022-2027)
    Table 78. Global Antibody-drug Conjugates Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 79. Global Antibody-drug Conjugates Revenue Market Share Forecast by Type (2022-2027)
    Table 80. Global Antibody-drug Conjugates Sales Forecast by Application (2022-2027) & (Kg)
    Table 81. Global Antibody-drug Conjugates Sales Market Share Forecast by Application (2022-2027)
    Table 82. Global Antibody-drug Conjugates Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 83. Global Antibody-drug Conjugates Revenue Market Share Forecast by Application (2022-2027)
    Table 84. Global Antibody-drug Conjugates Sales Forecast by Region (2022-2027) & (Kg)
    Table 85. Global Antibody-drug Conjugates Sales Market Share Forecast by Region (2022-2027)
    Table 86. Global Antibody-drug Conjugates Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 87. Global Antibody-drug Conjugates Revenue Market Share Forecast by Region (2022-2027)
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Antibody-drug Conjugates
    Figure 2. Global Antibody-drug Conjugates Market Share by Type in 2020 & 2027
    Figure 3. Adcetris Product Picture
    Figure 4. Kadcyla Product Picture
    Figure 5. Global Antibody-drug Conjugates Market Share by Application in 2020 & 2027
    Figure 6. Breast Cancer
    Figure 7. Lymphoma
    Figure 8. Global Antibody-drug Conjugates Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Antibody-drug Conjugates Market Size 2016-2027 (US$ Million)
    Figure 10. Global Antibody-drug Conjugates Sales 2016-2027 (Kg)
    Figure 11. Global Antibody-drug Conjugates Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 12. Antibody-drug Conjugates Sales Share by Manufacturers in 2020
    Figure 13. Global Antibody-drug Conjugates Revenue Share by Manufacturers in 2020
    Figure 14. The Global 5 and 10 Largest Antibody-drug Conjugates Players: Market Share by Revenue in 2020
    Figure 15. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 16. Global Antibody-drug Conjugates Sales Market Share by Region (2016-2021)
    Figure 17. Global Antibody-drug Conjugates Sales Market Share by Region in 2020
    Figure 18. Global Antibody-drug Conjugates Revenue Market Share by Region (2016-2021)
    Figure 19. Global Antibody-drug Conjugates Revenue Market Share by Region in 2020
    Figure 20. U.S. Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 21. Canada Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 22. Germany Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. France Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. U.K. Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. Italy Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. Russia Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. China Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Japan Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. South Korea Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. India Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. Australia Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. Taiwan Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Indonesia Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Thailand Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Malaysia Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Philippines Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Vietnam Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Mexico Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Brazil Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Argentina Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Turkey Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Saudi Arabia Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. U.A.E Antibody-drug Conjugates Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Sales Market Share of Antibody-drug Conjugates by Type (2016-2021)
    Figure 45. Sales Market Share of Antibody-drug Conjugates by Application (2016-2021)
    Figure 46. Sales Market Share of Antibody-drug Conjugates by Application in 2020
    Figure 47. Revenue Share of Antibody-drug Conjugates by Application (2016-2021)
    Figure 48. Revenue Share of Antibody-drug Conjugates by Application in 2020
    Figure 49. Manufacturing Cost Structure of Antibody-drug Conjugates
    Figure 50. Manufacturing Process Analysis of Antibody-drug Conjugates
    Figure 51. Antibody-drug Conjugates Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Torasemide API Market Research Report 2022
Global Torasemide API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-37B11450
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Baloxavir Marboxil API Market Research Report 2022
Global Baloxavir Marboxil API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-39E11527
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-29D11405
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Chemiluminescence Immunodiagnostic Market Research Report 2022
Global Chemiluminescence Immunodiagnostic Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-18X11631
Fri Aug 12 00:00:00 UTC 2022

Add to Cart